Venk is the co-founder and Chief Executive Officer of Nanowear, a New York-based connected-self technology platform for non-invasive diagnostics and chronic disease management built on first-of-its-kind cloth-based nanosensors. The Company was founded in September 2014 and received its first FDA 510(k) Class II clearance in December 2016 for SimplECG, an undergarment capturing and transmitting multi-channel ECG, heart rate and respiratory rate continuously via an iOS mobile application and HIPAA-compliant web portal. Nanowear’s first product launch, SimpleSense, is an undergarment for Congestive Heart Failure monitoring and management
Before Nanowear, Venk Varadan spent ~7 years in Technology Investment Banking, focusing exclusively on venture-backed software and communications technology in which he successfully advised growth companies in over $3bn USD worth of transactions at UBS Investment Bank, Citadel Investment Group and Wells Fargo Securities in New York. Prior to his Wall Street career, Venk spent ~ 3 years in sales and marketing at Eli Lilly and Sanofi Aventis Pharmaceuticals in New York.
Venk received his Masters of Business Administration from Columbia University in Finance & Entrepreneurship and his Bachelor of Science in Biochemistry from Duke University.